The present work endeavored to fill the above-mentioned knowledge gaps in our understanding of mPTT and tumor immunopathology, with a special focus pinned on how mPTT would affect the cross-talk of tumor cells and TAMs mediated by PD-L1/PD-1. This evidence concerns the gene PDCD1 and neoplasm.